Viewing Study NCT00004759


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-17 @ 3:18 PM
Study NCT ID: NCT00004759
Status: COMPLETED
Last Update Posted: 2008-09-10
First Post: 2000-02-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 199/11692
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View